Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
BMS1P17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SLC30A5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC101930531 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIAA0101 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
UBXN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNPO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CA5BP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GUCY1A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MCU - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHCHD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERO1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C3P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CBLN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXL4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APAF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on